期刊文献+

高效液相色谱法测定复方庚酸炔诺酮注射液的有关物质 被引量:1

Determination of Related Substances of Compound Norethisterone Enanthate Injection by HPLC
原文传递
导出
摘要 目的建立复方庚酸炔诺酮注射液有关物质检查的方法。方法采用HPLC梯度洗脱法,Phenomenex Gemini C18柱(4.6mm×250 mm,5μm),流动相A为水,流动相B为乙腈,流速为1.0 mL.min-1,检测波长220 nm,柱温35℃。结果主成分庚酸炔诺酮和戊酸雌二醇与各有关物质分离度良好。已知杂质炔诺酮和雌二醇分别在5.02~45.2和0.505~4.55μg.mL-1内线性关系良好,相关系数分别为1.000 0(n=5)和0.999 2(n=5),平均回收率(n=3)分别为99.4%和96.2%,RSD分别为0.9%和3.3%;庚酸炔诺酮和戊酸雌二醇自身对照溶液分别在2.42~121和0.242~12.1μg.mL-1内线性关系良好,相关系数均为1.000 0(n=6);炔诺酮、雌二醇、庚酸炔诺酮和戊酸雌二醇的检测限分别为7.3、2.0、0.9和1.2 ng。结论建立的HPLC能准确、灵敏、专属地测定复方庚酸炔诺酮注射液中的有关物质,经对不同生产日期的4批产品进行检验,本品有关物质的量与储存时间呈明显的相关性。 OBJECTIVE To establish an HPLC method for the determination of related substances of compound norethisterone enanthate injection. METHODS A Phenomenex Gemini C18 column (4.6 mm × 250 mm,5 μm) was used with water as mobile phase A and acetonitrile as mobile phase B. Gradient elution was used for the determination and the flow rate was 1.0 mL · min-1. The de- tection wavelength was 220 nm. The column temperature was maintained at 35 ℃ o RESULTS Norethisterone enanthate, estradiol valerate and their related substances were separated well. The calibration curves of the known related substances, namely norethisterone and estradiol, were linear within the concentration ranges of 5.02 - 45.2 and 0. 505 - 4.55 μg·mL^-1 with correlation coefficients of 1. 000 0 (n = 5) and 0.9992 ( n = 5), respectively. The average recoveries of norethisterone and estradiol were 99.4% and 96.2% (n = 3), with RSDs of 0.9% and 3.3%, respectively. The self-reference standard solution of norethisterone enanthate and estradiol valerate were linear within the concentration ranges of 2.42 - 121 and 0.242 - 12.1 μg·mL^-1 , and the correlation coefficients were both 1. 000 0 ( n = 6). The LODs of norethisterone, estradiol, norethisterone enanthate, and estradiol valerate were 7.3, 2.0, 0.9 and 1.2 ng, respectively. CONCLUSION The method is accurate, sensitive, and specific. The analsis results of four batches of compound norethisterone enanthate injection showed that there is an evident correlationship between the amount of related substances and storage time of the injection.
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第23期1947-1951,共5页 Chinese Pharmaceutical Journal
关键词 高效液相色谱法 复方庚酸炔诺酮注射液 炔诺酮 雌二醇 HPLC compound norethisterone enanthate injection norethisterone estradiol
  • 相关文献

参考文献7

  • 1EL-MAHGOUB S,KARIM M. The long-term use of injectable norethisterone enanthate as a contraceptive[J]. Contraception,1972,5(1):21-29.
  • 2Family Planning Research Institute, Zhejiang Academy of Experimental Medicine and Hygiene,et al. Clinical pharmacological study on different doses of norethisterone oenanthate(NET-OEN)as a long-acting injectable contraceptive[J].中国临床药理学杂志,1985,1(2):98-105.
  • 3KESSERU E V,AYDINLIK S,ETCHEPAREBORDA J J. Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive, final three-year report[J]. Contraception,1994,50(4):329-337.
  • 4Ch.P(2010)Vol Ⅱ(中国药典2010年版.二部)[S].2010:52.104-105.
  • 5FLOREY K. Analytical Profiles of Drug Substances[M]. Vol. 4. New York:Academic Press, 1975.
  • 6CEN M Z,WU Z J,SHEN Z R,et al. Improved preparation of norethindrone enanthate [J]. 医药工业,1988,19(1):33-34.
  • 7王国强,林芳,王尊元,吴月国.庚炔诺酮的制备[J].中国医药工业杂志,2008,39(1):9-10. 被引量:1

二级参考文献3

  • 1岑美芝,吴志骏,沈正荣,李载生.庚炔诺酮合成工艺的改进[J].医药工业,1988(1):33-34. 被引量:1
  • 2李英.介绍一类高效酰化催化剂—二烷基氨基吡啶[J].化学试剂,1982,4(2):88-88.
  • 3Hofle G, Steglich W, Vorbruggen H. 4-Dialkylaminopyridines as highly active acylation catalysts [J]. Angew Chem Int Ed Engl, 1978, 17 (8) : 569-583.

同被引文献12

  • 1王红枫,刘全忠,齐蔓莉.沙眼衣原体E血清型的小鼠生殖道感染模型初步研究[J].中华皮肤科杂志,2006,39(5):296-297. 被引量:9
  • 2李靖,李炫诚,吴云霞.确定小鼠动情周期的三种方法[J].实验动物科学,2007,24(3):63-64. 被引量:43
  • 3Pal S, Peterson EM, de la Maza LM. Susceptibility of mice to vaginal infection with Chlamydia trachomatis mouse pneumonitis is dependent on the age of the animal [ J ]. Infect Immun, 2001, 69 ( 8 ): 5203-5206.
  • 4Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis [J]. FEMS Microbiology Letters, 1981, 12 (2): 111-115.
  • 5Kaushic C, Murdin AD, Underdown BJ, et al. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response [J ]. Infect Immun, 1998, 66(3): 893-898.
  • 6Lyons JM, Ito JI, Morr6 SA. Efficacy of an immune modulator in experimental Chlamydla trachomatis infection of the female genital tract [J/OL]. Infect Dis Obstet Gynecol, 2006, 2006: 61265:2014- 11-051. http://www .ncbi.nlm.nih.gov/pmc/articles/[M] 1581471.
  • 7Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study [Jl. Am J Obstet Gynecol, 2001, 185 (2): 380- 385.
  • 8el-Mahgoub S, Karim M. The long-term use of injectable norethisterone enanthate as a contraceptive[J]. Contraception, 1972, 5( 1 ): 21-29.
  • 9浙江卫生实验院计划生育研究所.不同剂量炔诺酮庚酸酯长效避孕针的临床药理学研究[J].中国临床药理学杂志,1985,1(2):98-105.
  • 10王乐丹,颜林志,孟锐锋,张丽芳.沙眼衣原体感染小鼠生殖道模型的初步研究[J].中国人兽共患病学报,2011,27(8):692-695. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部